Immix... recnac latceroloc ni 011-XMI r-io.net

Current Location: Home >Breaking News >Immix... recnac latceroloc ni 011-XMI r Details

Immix... recnac latceroloc ni 011-XMI r

Date: 2025-05-21 18:49:52 Source: io.net Author: DeFi Views: 169

Immix Biopharma (NASDAQ:IMMX) reported early interim data from a phase 1b/2a trial of IMX-110 in combination with Novartis (NYSE:NVS) and BeiGene's (NASDAQ:BGNE) tislelizumab to treat patients with ad... Stay informed with the latest.

(Editor-in-Chief: Tech & Dev)

[1]

[2]

[3]

Previous: This... 02$ tsuj stsoc ti dna ,doog yl
Next: Adobe... esu ot efas si syas ti taht